Surveillance of antimicrobial resistance at a tertiary hospital in Tanzania

Bjørn Blomberg, Davis S M Mwakagile, Willy K Urassa, Samwel Y Maselle, Marcellina Mashurano, Asbjørn Digranes, Stig Harthug, Nina Langeland, Bjørn Blomberg, Davis S M Mwakagile, Willy K Urassa, Samwel Y Maselle, Marcellina Mashurano, Asbjørn Digranes, Stig Harthug, Nina Langeland

Abstract

Background: Antimicrobial resistance is particularly harmful to infectious disease management in low-income countries since expensive second-line drugs are not readily available. The objective of this study was to implement and evaluate a computerized system for surveillance of antimicrobial resistance at a tertiary hospital in Tanzania.

Methods: A computerized surveillance system for antimicrobial susceptibility (WHONET) was implemented at the national referral hospital in Tanzania in 1998. The antimicrobial susceptibilities of all clinical bacterial isolates received during an 18 months' period were recorded and analyzed.

Results: The surveillance system was successfully implemented at the hospital. This activity increased the focus on antimicrobial resistance issues and on laboratory quality assurance issues. The study identified specific nosocomial problems in the hospital and led to the initiation of other prospective studies on prevalence and antimicrobial susceptibility of bacterial infections. Furthermore, the study provided useful data on antimicrobial patterns in bacterial isolates from the hospital. Gram-negative bacteria displayed high rates of resistance to common inexpensive antibiotics such as ampicillin, tetracycline and trimethoprim-sulfamethoxazole, leaving fluoroquinolones as the only reliable oral drugs against common Gram-negative bacilli. Gentamicin and third generation cephalosporins remain useful for parenteral therapy.

Conclusion: The surveillance system is a low-cost tool to generate valuable information on antimicrobial resistance, which can be used to prepare locally applicable recommendations on antimicrobial use. The system pinpoints relevant nosocomial problems and can be used to efficiently plan further research. The surveillance system also functions as a quality assurance tool, bringing attention to methodological issues in identification and susceptibility testing.

References

    1. Cohen ML. Epidemiology of drug resistance: implications for a post-antimicrobial era. Science. 1992;257:1050–1055.
    1. Tenover FC, Hughes JM. The challenges of emerging infectious diseases. Development and spread of multiply-resistant bacterial pathogens. JAMA. 1996;275:300–304. doi: 10.1001/jama.275.4.300.
    1. Acar JF. Consequences of bacterial resistance to antibiotics in medical practice. Clin Infect Dis. 1997;24 Suppl 1:S17–8.
    1. Hart CA, Kariuki S. Antimicrobial resistance in developing countries. Bmj. 1998;317:647–650.
    1. Stamm W, Grayson ML, Nicolle L, Powell M. WHO Global Strategy for Containment of Antimicrobial Resistance (Document no: WHO/CDS/CSR/DRS/2001.2) Geneva, World Health Organization; 2001.
    1. O'Brien TF. The global epidemic nature of antimicrobial resistance and the need to monitor and manage it locally. Clin Infect Dis. 1997;24 Suppl 1:S2–8.
    1. Stelling JM, O'Brien TF. Surveillance of antimicrobial resistance: the WHONET program. Clin Infect Dis. 1997;24 Suppl 1:S157–68.
    1. Collee J Gerald, Marmion Barrie P, Irvine Robert, Fraser Andrew G, Simmons Anthony. Mackie & McCartney Practical Medical Microbiology. 14. New York, Churchill Livingstone; 1996. p. 978.
    1. Joan Stokes E, Ridgeway GL. Clinical Bacteriology. 6th. London, Edward Arnold; 1987.
    1. Tenover FC, Mohammed MJ, Stelling J, O'Brien T, Williams R. Ability of laboratories to detect emerging antimicrobial resistance: proficiency testing and quality control results from the World Health Organization's external quality assurance system for antimicrobial susceptibility testing. J Clin Microbiol. 2001;39:241–250. doi: 10.1128/JCM.39.1.241-250.2001.
    1. Livermore DM, Threlfall EJ, Reacher MH, Johnson AP, James D, Cheasty T, Shah A, Warburton F, Swan AV, Skinner J, Graham A, Speller DC. Are routine sensitivity test data suitable for the surveillance of resistance? Resistance rates amongst Escherichia coli from blood and CSF from 1991-1997, as assessed by routine and centralized testing. J Antimicrob Chemother. 2000;45:205–211. doi: 10.1093/jac/45.2.205.
    1. Omari MA, Malonza IM, Bwayo JJ, Mutere AN, Murage EM, Mwatha AK, Ndinya-Achola JO. Pattern of bacterial infections and antimicrobial susceptibility at the Kenyatta National Hospital, Nairobi, Kenya. East Afr Med J. 1997;74:134–137.
    1. Malonza IM, Omari MA, Bwayo JJ, Mwatha AK, Mutere AN, Murage EM, Ndinya-Achola JO. Community acquired bacterial infections and their antimicrobial susceptibility in Nairobi, Kenya. East Afr Med J. 1997;74:166–170.
    1. Kariuki S, Gilks C, Corkill J, Kimari J, Benea A, Waiyaki P, Hart CA. Multi-drug resistant non-typhi salmonellae in Kenya. J Antimicrob Chemother. 1996;38:425–434.
    1. Lepage P, Bogaerts J, Van Goethem C, Ntahorutaba M, Nsengumuremyi F, Hitimana DG, Vandepitte J, Butzler JP, Levy J. Community-acquired bacteraemia in African children. Lancet. 1987;1:1458–1461. doi: 10.1016/S0140-6736(87)92207-0.
    1. Dornbusch K, King A, Legakis N. Incidence of antibiotic resistance in blood and urine isolates from hospitalized patients. Report from a European collaborative study. European Study Group on Antibiotic Resistance (ESGAR) Scand J Infect Dis. 1998;30:281–288. doi: 10.1080/00365549850160945.
    1. Maselle SY, Mhalu FS, Ipuge YA, Urassa WK. Surveillance of antibiotic sensitivity of gram-positive cocci in a national consultant hospital in Dar es Salaam, Tanzania - a guide to antimicrobial therapy. Medicom. 1985;7:11–13.
    1. Urassa WK, Haule EA, Kagoma C, Langeland N. Antimicrobial susceptibillty of Staphylococcus aureus strains at Muhimbili Medical Centre, Tanzania. East Afr Med J. 1999;76:693–695.
    1. George RC, Uttley AH. Susceptibility of enterococci and epidemiology of enterococcal infection in the 1980s. Epidemiol Infect. 1989;103:403–413.
    1. Venditti M, Fimiani C, Baiocchi P, Santini C, Tarasi A, Capone A, Di Rosa R, Micozzi A. Infections by ampicillin-resistant enterococci: a case-control study. J Chemother. 1994;6:121–126.
    1. Pallares R, Pujol M, Pena C, Ariza J, Martin R, Gudiol F. Cephalosporins as risk factor for nosocomial Enterococcus faecalis bacteremia. A matched case-control study. Arch Intern Med. 1993;153:1581–1586. doi: 10.1001/archinte.153.13.1581.
    1. Baquero F. Pneumococcal resistance to beta-lactam antibiotics: a global geographic overview. Microb Drug Resist. 1995;1:115–120.
    1. Kell CM, Jordens JZ, Daniels M, Coffey TJ, Bates J, Paul J, Gilks C, Spratt BG. Molecular epidemiology of penicillin-resistant pneumococci isolated in Nairobi, Kenya. Infect Immun. 1993;61:4382–4391.
    1. Mbwana J, Mhalu F, Mwakagile D, Masesa J, Moshiro C, Sandstrom E. Susceptibility pattern of Neisseria gonorrhoeae to antimicrobial agents in Dar es Salaam. East Afr Med J. 1999;76:330–334.
    1. Haug JB, Harthug S, Kalager T, Digranes A, Solberg CO. Bloodstream infections at a Norwegian university hospital, 1974-1979 and 1988-1989: changing etiology, clinical features, and outcome. Clin Infect Dis. 1994;19:246–256.
    1. Willett WC, Radojcic V. Urinary tract pathogens and antibiotic sensitivity patterns in Dar es Salaam. East Afr Med J. 1976;53:685–692.
    1. Maselle SY, Ipuge YA, Mhalu FS. Antimicrobial susceptibility patterns of important urinary bacterial pathogens in Muhimbili Medical Centre, Dar es Salaam. Dar es Salaam Medical Journal. 1980;8:35–40.
    1. Urassa WK, Mwakagile D, Mohammed K, Msangi V. Susceptibility pattern of uropathogenic gram negative bacilli to antimicrobial chemotherapeutic agents in a National Hospital in Dar es Salaam. East Afr Med J. 1997;74:162–165.
    1. Slack RC, Wamola IA. Aminoglycoside resistance in gram-negative rods isolated from clinic specimens in Kenya. East Afr Med J. 1977;54:552–555.
    1. Yu WL, Chuang YC, Jones RN. A pragmatic approach to identify extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in Taiwan: in vitro activity of newer and established antimicrobial agents. Diagn Microbiol Infect Dis. 2004;48:277–282. doi: 10.1016/j.diagmicrobio.2003.11.001.
    1. Mhalu FS, Mmari PW, Ijumba J. Rapid emergence of El Tor Vibrio cholerae resistant to antimicrobial agents during first six months of fourth cholera epidemic in Tanzania. Lancet. 1979;313:345–347. doi: 10.1016/S0140-6736(79)92889-7.
    1. NCCLS . Performance Standards for Antimicrobial Disk Susceptibility Tests, Approved Standard M2-A7. 7th. Wayne, PA, USA, National Committee for Clinical Laboratory Standards; 1997.
    1. Bronzwaer S, Buchholz U, Courvalin P, Snell J, Cornaglia G, de Neeling A, Aubry-Damon H, Degener J. Comparability of antimicrobial susceptibility test results from 22 European countries and Israel: an external quality assurance exercise of the European Antimicrobial Resistance Surveillance System (EARSS) in collaboration with the United Kingdom National External Quality Assurance Scheme (UK NEQAS) J Antimicrob Chemother. 2002;50:953–964. doi: 10.1093/jac/dkf231.
    1. Cornaglia G, Hryniewicz W, Jarlier V, Kahlmeter G, Mittermayer H, Stratchounski L, Baquero F. European recommendations for antimicrobial resistance surveillance. Clin Microbiol Infect. 2004;10:349–383. doi: 10.1111/j.1198-743X.2004.00887.x.
    1. Blomberg B. The Guardian. Dar es Salaam, Tanzania; 2001. Fake medicines, a threat to human health (letter) p. 6.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa